Similarly, lymphopenia induced autoimmunity might explain the increased risk of anti-IFNβ ADA development in older MS-patients: chronic stimuli with IFNβ might induce homeostatic proliferation of effector T cells against a self-antigen not paralleled by an appropriate thymopoiesis of novel regulatory T cells. This evidence concerns the gene IFNB1 and lymphopenia.